Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | RXRA | P19793 | 1/20 | 0.42 |
| ▸ | RXRB | P28702 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 2/20 | 0.41 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.41 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.41 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18563969 | 0.96 | L3MBTL1 (0.44) | L3MBTL1KDM4EATMRXRARXRB | |
| SCHEMBL18566268 | 0.96 | KDM4E (0.49) | L3MBTL1KDM4EATMRXRARXRB | |
| SCHEMBL18563977 | 0.95 | KDM4E (0.50) | L3MBTL1KDM4EATMRXRARXRB | |
| SCHEMBL18563981 | 0.94 | KDM4E (0.44) | L3MBTL1KDM4EATMRXRARXRB | |
| SCHEMBL18563975 | 0.94 | KDM4E (0.44) | L3MBTL1KDM4EATMRXRARXRB | |
| SCHEMBL18563933 | 0.94 | KDM4E (0.44) | L3MBTL1KDM4EATMRXRARXRB | |
| SCHEMBL18563947 | 0.92 | RXRA (0.46) | L3MBTL1KDM4EATMRXRARXRB | |
| SCHEMBL18563985 | 0.92 | RXRA (0.46) | L3MBTL1KDM4EATMRXRARXRB | |
| SCHEMBL18566273 | 0.92 | KDM4E (0.42) | L3MBTL1KDM4EATMRXRARXRB | |
| SCHEMBL18563995 | 0.91 | KDM4E (0.46) | L3MBTL1KDM4EATMRXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10290815-B2 | Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-05-14 | — | — | US | disclosed |
| US-20170062733-A1 | COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-03-02 | — | — | US | disclosed |
| US-20170062733-A1 | COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10290815-B2 | Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device | EED, BMI1, CD99 | L3MBTL1 1263/4885KDM4E 225/4885ATM 3092/4885 |
| US-20170062733-A1 | COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | EED, BMI1, CD99 | L3MBTL1 1263/4885KDM4E 225/4885ATM 3092/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.